Company / Capital Expenditures
Century Therapeutics, Inc. Capital Expenditures History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$154.0K
FY2025
5-year range
$154.0K / $45.0M
FY2022-FY2025
Trend
-98.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures has declined for 3 consecutive years, from $45M in FY2022 to $154,000 in FY2025.
Based on SEC 10-K filings.
$154,000 in FY2025 with a 3-year CAGR of -84.9%.
Declined from $31M to $154,000 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -84.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Century Therapeutics, Inc.'s capital expenditures has declined for 3 consecutive years.
- 3-year CAGR of -84.9%, indicating a declining trend.
- In FY2025, capital expenditures decreased 98.9% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $154.0K | -98.9% |
| FY2024 | $13.7M | -55.1% |
| FY2023 | $30.6M | -31.9% |
| FY2022 | $45.0M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026